ITG has received the Manufacturing License for Lu-177 n.c.a.
Monday, 23 January 2012 08:45

As of December 2011, ITG Isotope Technologies Garching GmbH has successfully passed the audit of the GMP production of the Lu-177 n.c.a. and has subsequently received the “Herstellungserlaubnis”. More than 15 reactors and accelerators in Europe, Australia, Africa, Russia and the FRM II form a network of irradiation facilities for ITG´s radioisotopes.

 

For further inquiries or if you would like to schedule a meeting with our representatives please contact: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

 

 

News

ITG Isotope Technologies Garching GmbH (Germany) announces broad collaboration with ANSTO (Australia) on radioisotopes

Garching, Germany, June 3, 2011. ITG Isotope Technologies Garching GmbH (ITG), a specialist in the development and production of innovative...
Read more...

Helmholtz Zentrum München and ITM AG enter antibody deal

Ascenion has mediated a license agreement between the Helmholtz Zentrum München and ITM Isotopen Technologien München AG providing the company...
Read more...

IMETUM and ITM AG enter into scientific collaboration

The Technical University of Munich’s Central Institute for Medical Technologies (IMETUM) and the ITM Group have initiated a collaborative scientific...
Read more...